Smaller DTC Budgets, But More Info-Packed Drug Ads Expected In 2009
Drug companies will continue to scale back funds for televised ads in 2009, largely in order to save money, but also because they are increasingly sensitive to public perception at a time when consumers are struggling financially
You may also be interested in...
Prevacid, Topamax Among Blockbusters Set To Lose Exclusivity In ’09
At least four blockbuster drugs could face generic rivals in the U.S. for the first time in 2009
FDA Advertising Oversight Will Consider Impact Of “Puppies” And The Internet
FDA is pushing forward several research initiatives to help better define how print and broadcast direct-to-consumer ads should be structured, but the agency is adopting a less formal approach to oversight of Internet advertising
Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.